March 8, 2023
Uncontrollable movements. Memory loss. Personality changes. Difficulty eating and drinking. These are all common experiences for patients with Huntington’s disease, making independent living and interpersonal relationships tremendously difficult.
February 16, 2023
Affecting 6 million Americans, Alzheimer’s disease permanently alters families and communities across the United States. For patients and their loved ones, the most frightening aspect of an Alzheimer’s diagnosis may not be the eventual fatal outcome. It’s the mental and physical deterioration that is, in many cases, prolonged over the course of years.
February 9, 2023
Nearly half of Americans report symptoms of anxiety or depressive disorder.
February 2, 2023
ICER’s cost-effectiveness analysis doesn’t wholly depict
the value of new Alzheimer’s medications.
February 2, 2023
ICER released its draft evidence report on beta-amyloid antibodies for early Alzheimer’s disease.
January 25, 2023
From difficult symptoms to an accurate diagnosis to effective treatment, the rare disease journey is a long one. But despite the challenges patients face, innovation and education are regularly improving lives.
January 11, 2023
RSV, or respiratory syncytial virus, is a common, highly contagious seasonal virus that affects 97% of children by the age of 2.
January 4, 2023
Alzheimer’s disease and other forms of dementia have long impacted families
and communities across the country. Today, about 6 million Americans live
with Alzheimer’s disease — a number that will more than double by 2050.
December 19, 2022
The seventh annual National Policy & Advocacy Summit on Biologics brought together health care providers, policy experts, patient advocates and other stakeholders.
December 19, 2022
At some point in their lives, most patients encounter insurance delays or denials for a prescription medication. But do certain groups of patients encounter these barriers more often than others? And at what cost?
